Opinion|Videos|November 4, 2024
Prostate Cancer and Intimacy
Key Takeaways
- Advanced prostate cancer treatment can affect intimacy and QOL, necessitating open communication with healthcare providers.
- Patients should articulate their treatment goals and preferences to influence decision-making and treatment aggressiveness.
Panelists discuss how the diagnosis and treatment of advanced prostate cancer can significantly impact intimacy and relationships, emphasizing the importance of open communication about goals and preferences in treatment decisions, while also sharing strategies for self-advocacy and maintaining quality of life (QOL) throughout the treatment journey.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How can the diagnosis and treatment of advanced prostate cancer affect intimacy for patients? What advice do you offer patients?
- How has your diagnosis and treatment impacted your intimate relationships, and what advice would you give to others?
TOPIC IV: Advocating for Yourself (~5 minutes)
- How important is it for patients to share their goals and preferences in treatment decisions? What role do their preferences play in your treatment decisions, including how aggressive to be?
- How did you speak up for yourself during your treatment journey? What strategies worked for you? What advice would you offer others?
- What should patients consider when talking to their doctors about the risks and benefits of treatments?
- What were your main concerns, and how did you talk about them with your doctor? Do you have any questions that someone going through a similar journey should ask their care team?
- How do QOL issues affect treatment decisions?
- How has your treatment impacted your daily life and overall QOL? Did you have any strategies to help maintain your QOL and continue to be able to do what was important to you?
Advertisement
Related to this article
Up to 40% of patients with classic hairy cell leukemia relapse within 10 to 15 years. An NIH researcher explains how adding Rituxan up front may help.
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
Most people with pancreatic cancer lose weight they didn't mean to. Here is how weight loss from poor digestion differs from cachexia, and what enzymes, eating strategies and appetite medicines can do.
Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.
In a study of 8,259 rural Medicare patients with advanced non-small cell lung cancer diagnosed from 2014 to 2019, only 35.9% had tumor gene testing, and those who were tested were more likely to get targeted therapy.
Among U.S. adults with a history of cancer, 45.8% reported drinking alcohol in the past 30 days in both 2016 and 2024, while drinking declined among adults without cancer, according to a study in Cancer Causes & Control of nearly 4 million adults.
Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, discusses why every patient with glioblastoma should have their tumor profiled, and what patients can ask their care team.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
3
Weight Loss With Pancreatic Cancer: Why It Happens and What Helps
4
Glioblastoma Patients Can Request Genomic Testing on Their Tumor Tissue
5